for further workup and possible antibiotic therapy. Several methods of evaluation and diagnostic strategies have recently been suggested, but the need for a screening test remains a source of considerable debate.
Granulocyte colony-stimulating factor (G-CSF) is a colony-stimulating factor that not only augments the number of granulocytes, but also activates their microbicidal activity and inhibits their apoptotic response. The potential of G-CSF to enhance the host's inflammatory response to infection has been extensively investigated [4] . Chemokines (chemoattractant cytokines) represent a superfamily of small secreted proteins that function as intercellular messengers controlling the migration and activation of leukocytes involved in inflammatory reactions and immunity. Chemokines and proinflammatory cytokines are essential for initiation of the inflammatory response and defense against microbial infection [5, 6] . Cells in most inflamed or infected tissues can release a variety of chemokines, and tissues infected with different bacteria release chemokines that recruit immune cells to sites of inflammation. Hence, chemokines play important roles at various stages throughout the infectious process [6, 7] .
The aim of this study was to evaluate and compare the diagnostic values of circulating levels of G-CSF and various potential chemokines for the early diagnosis of SBI in young febrile infants < 3 months of age.
PATIENTS AND METHODS

Ethical approval
The study was approved by the Human Experiment and Ethics Committee of Kaohsiung Medical University Hospital and informed consent was obtained from the parents of all patients before enrolment.
Patients
Febrile young infants < 3 months of age with clinically suspected SBI who were admitted to the neonatal intensive care unit or complete nursing unit of the pediatric department of Kaohsiung Medical University Hospital between December 2006 and July 2007 were enrolled. The infants were suspected of having SBI if they had at least one of the following signs or symptoms: tachypnea, dyspnea, tachycardia, bradycardia, reduced activity, lethargy, or decreased appetite. Diagnostic work-up, including bacterial cultures, was performed to identify or rule out bacterial infection. Antibiotic therapy was prescribed for all enrolled patients at admission. Blood was collected at admission for the measurement of complete blood counts, C-reactive protein (CRP), and plasma chemokine levels. All infants included in the study were admitted to our hospital from the community; nosocomially infected infants were excluded.
SBI was defined as bacterial pathogens isolated from the cerebrospinal fluid or blood, a UTI, or pneumonia. Pneumonia was diagnosed by the presence of related clinical symptoms, such as tachypnea or a productive cough, along with a positive finding on chest X-ray. A UTI was diagnosed as pyuria and two sets of urine cultures with a single pathogen growth of > 10 4 colony forming units/mL from a bladder catheterization, or > 10 5 colony forming units/mL collected from a sterile collection bag [8] . The absolute neutrophil counts (ANC) and immature neutrophils/total neutrophils (IT ratio) were calculated according to the white blood cell (WBC) differential counts. The medical records of all patients with positive cerebrospinal fluid, blood, or urine cultures were thoroughly reviewed.
Measurement of CRP and circulating chemokine levels in plasma
Blood samples were collected in EDTA tubes at admission, and centrifuged immediately. The plasma samples for CRP levels were analyzed using rate turbidimetry (SYNCHRON ® System(s)), Beckman Coulter Ireland Inc., Galway, Ireland). Plasma was frozen at -80°C until analysis of chemokines. Human Chemokines 6plex FlowCytomix Multiplex assay (Bender MedSystems GmbH, Vienna, Austria) was used according to the manufacturer's instructions to measure circulating levels of G-CSF and chemokines, including interleukin-8 (IL-8), macrophage inflammatory protein-1α (MIP-1α), macrophage inflammatory protein-1β (MIP-1β), monokine induced by interferon-γ (MIG), and monocyte chemotactic protein-1 (MCP-1). This assay requires a 25-μL serum sample. The standard ranges for this assay were: G-CSF, 34.3-25,000 pg/mL; IL-8, 13.7-10,000 pg/mL; MCP-1, 41.2-30,000 pg/mL; MIG, 6.9-5,000 pg/mL; MIP-1α, 13.7-10,000 pg/mL; and MIP-1β, 4.1-3,000 pg/mL.
Statistical analysis
Data entry and statistical analysis were performed using SPSS version 11.5 (SPSS Inc., Chicago, IL, USA).
Both median and range were calculated for continuous data. Variables were tested for their association with the diagnosis using χ 2 tests for categorical data and Mann-Whitney U tests for numerical data. The diagnostic values of the different variables and the best cutoff values were determined using receiveroperating characteristic (ROC) curves. Sensitivity, specificity, and positive and negative predictive values were calculated for the cutoff points that represented the best discrimination, as derived from the areas under the ROC curves. Correlations between chemokine levels and biological features or clinical outcomes were assessed using Spearman's correlation tests. A two-tailed p value < 0.05 was considered statistically significant.
RESULTS
Forty-three febrile infants < 3 months of age who were admitted to the pediatric department of Kaohsiung Medical University Hospital were enrolled in this study. A total of 26 infants (60.5%) were diagnosed with SBI, while 17 (39.5%) had no evidence of SBI, based on the results of bacterial cultures. The characteristics and clinical findings of these two groups are shown in Table 1 . There were no differences in sex or age between the two groups. Significantly greater percentages of infants with SBI had respiratory distress symptoms (tachypnea, chest retraction, cyanosis, nasal flaring, or grunting) and gastrointestinal symptoms (decrease of appetite, vomiting, or diarrhea), compared with infants without SBI. There were no differences between the groups in terms of vital signs recorded at admission, including body temperature, pulse rate, and respiratory rate. and Enterococcus faecalis (n = 3) were also identified.
The laboratory tests at initial evaluation (Table 2 ) revealed no significant differences between the two groups in terms of total WBC counts, ANC, IT ratios, hemoglobin, or platelet counts. CRP, IL-8, and G-CSF levels, however, were significantly higher in infants with SBI. Levels of other plasma chemokines, such as MIP-1α, MIP-1β, MIG, and MCP-1 were comparable between the groups.
The sensitivity, specificity, positive predictive value, negative predictive value, and the best cutoff values of CRP, IL-8, and G-CSF based on ROC analysis are presented in Table 3 . The diagnostic properties of CRP, IL-8, and G-CSF levels were compared by calculating the areas under the ROC curves. The areas under the ROC curves for differentiating between the presence and absence of SBI were 0.79 (95% CI, 0.65-0.92) for CRP levels, 0.71 (95% CI, 0.56-0.86) for IL-8 levels, and 0.68 (95% CI, 0.52-0.84) for G-CSF (Table 3) . CRP with a cutoff value of 13.6 μg/mL had a better diagnostic accuracy than IL-8 or G-CSF levels for predicting febrile infants with SBI at initial survey. Diagnostic accuracy was further improved by combining CRP with either IL-8 or G-CSF, for which the areas under ROC curves were increased to 0.91 and 0.81, respectively (Table 3; Figure) .
There was positive correlation between IL-8 levels and the length of hospital stay (Spearman's correlation coefficient = 0.419, p = 0.005). No correlation was found between levels of CRP or other chemokines and clinical outcome. There were no correlations between chemokine levels, CRP levels, total WBC count, ANC, IT ratio, and microbial species.
DISCUSSION
In this study, we simultaneously evaluated levels of CRP, G-CSF and several chemokines (MIP-1α, IL-8, MIP-1β, MIG, and MCP-1), and demonstrated that CRP had the best specificity and sensitivity for predicting SBI in febrile infants < 3 months of age. However, the combinations of CRP with IL-8 or G-CSF were superior to CRP alone for the early prediction of *Continuous data presented as median (range). WBC = white blood cell; IT ratio = immature neutrophils/total neutrophils; CRP = C-reactive protein; G-CSF = granulocyte colony-stimulating factor; IL-8 = interleukin-8; MIP-1α = macrophage inflammatory protein-1α; MIP-1β = macrophage inflammatory protein-1β; MCP-1 = monocyte chemotactic protein-1; MIG = monokine induced by interferon-γ. SBI in these infants. MIP-1α, MIP-1β, MIG, and MCP-1 levels, however, could not be used to differentiate between SBI and non-SBI diseases in febrile young infants.
Early identification and management of SBI in febrile young infants is needed due to the less effective defense system of young infants and the high morbidity associated with SBI [2] . Unfortunately, however, there are currently no reportedly reliable clinical symptoms, signs, or laboratory tests suitable for the early diagnosis of SBI in these patients. Bacterial cultures provide the gold standard procedure for detecting occult SBI, but the results of this procedure are not promptly available. Efforts to find a reliable marker for the early identification of SBI are therefore ongoing.
Total WBC count, ANC, and immature neutrophil levels are the common tests used for screening SBI in clinical settings. These tests, however, are not always able to distinguish between bacterial infections and respiratory viral infections in young febrile children [9] [10] [11] [12] , as shown in the current study. CRP has recently become the most commonly used marker for both the early recognition of clinically undetectable SBI and an indicator of the need for further management. CRP concentration has been reported to be both more sensitive and more specific than either total WBC count or ANC [13] [14] [15] . Although CRP demonstrated good diagnostic accuracy in this study, previous reports have found CRP to be an unsatisfactory marker for identifying young infants with SBI [16] [17] [18] . A single CRP measurement cannot be used to definitively diagnose SBI [18] .
Chemokines have recently become a focus of interest for inflammation and infection research. Chemokines play a major role in diseases with an accentuated inflammatory component, and have been found at similar levels in the serum of neonates and adults [19] [20] [21] [22] . Among the various chemokines, IL-8 is produced predominantly by monocytes, macrophages, and endothelial cells in response to various stimuli, such as lipopolysaccharide and tumor necrosis factor-α [23] . This chemokine is one of the major mediators of the inflammatory response. IL-8 plays an important role in the release, activation, and chemotaxis of neutrophils. Several studies have shown that serum IL-8 levels are increased in newborns with culture-proven sepsis [24] [25] [26] [27] [28] [29] . Kurt et al and Kocabas et al also reported that plasma IL-8 levels were higher in septic than in non-septic newborn infants [24, 26] . We also found a positive correlation between IL-8 levels and the length of hospital stay. This suggests that IL-8 could serve as a predictor of disease outcome, but not as a good indicator of SBI. However, we found that levels of IL-8 and G-CSF, a factor influencing neutrophil function, were significantly increased in the SBI group and showed high specificity for differentiating bacterial infection in febrile infants.
CRP, IL-8, and G-CSF alone demonstrated moderate accuracies (areas under the ROC curves 0.7-0.9) for diagnosing SBI in febrile infants. However, the accuracy was improved (area under the ROC curve > 0.9) by combining IL-8 and CRP values. This result implies that CRP and IL-8 levels could serve as indicators for the early prescription of antibiotics.
In conclusion, these results demonstrate that CRP levels are superior to IL-8 and G-CSF levels for predicting SBI in febrile infants at initial survey. The combination of the inflammatory marker IL-8 with CRP could improve the sensitivity and specificity of SBI detection in febrile young infants, thus allowing clinicians to treat these patients more appropriately. 
